Multi Drug Resistant Tuberculosis in Bhutan: A Look into The Line Probe Assay Results |Biomedgrid
Journal: American Journal of Biomedical Science & Research (Vol.12, No. 5)Publication Date: 2021-04-27
Authors : Sonam Pelden; Lila Maya Adhikari; Kinley Gyem; Pavitra Bhujel; Tshering Dorji; Ugyen Dorji; Lekey Khandu; Jit Bdr Darnal;
Page : 471-478
Keywords : Tuberculosis; Multi drug resistance; Bhutan; Genotypic; Treatment;
Abstract
Bhutan plans to end TB by 2030 in line with the WHO End TB by 2030 goal. In 2016 National tuberculosis reference laboratory (NTRL) has performed Line probe assay (LPA) on 506 TB isolates, a huge jump from 326 cases in 2015.
Other Latest Articles
- Heart Rate Variability and Perceptual Well-Being in Triathlon – A Case Report |Biomedgrid
- A Novel HBA1 Gene Polymorphism in Vietnamese Population: C.172G>A (P. Gly58Ser) |Biomedgrid
- Ageing and Increasing Doses are Factors Related to Delays for Adults with Haemophilia to Seek Prophylactic Clotting Factors |Biomedgrid
- Hiccups in COVID-19: A rare complaint with many possible causes |Biomedgrid
- Importance of Further Research on Leishmania Biology |Biomedgrid
Last modified: 2023-08-17 21:56:25